OnCore Login

Return to Trial Database

HCRN-LUN01-15

A Phase III Randomized Study of Taxotere 75/mg/M2 vs. ALIMTA for Second-line Chemo for Non-Small Cell Lung Cancer

Status

Study Completed

Cancer Type(s)

Lung

Study Contact

Publications

A Phase III Study of Pemetrexed vs Docetaxel in Patients with Recurrent Non-Small Cell Lung Cancer (NSCLC) who were Previously Treated with Chemotherapy
  • N Hanna, FA Shepherd, R Rosell, JR Pereira, F De Marinis, FV Fossella, L Kayitalire, S Paul, L Einhorn, PA Bunn
Randomized Phase III Trial of Pemetrexed versus Docetaxel in Patients with Non-small Cell Lung Cancer Previously Treated with Chemotherapy
  • N Hanna, F Shepherd, F Fossella, J Pereira, F De Marinis, J von Pawel, UGatzemeier, T Tsao, M Pless, T Muller, H Lim, C Desch, K Szondy, R Gervais, Shaharyar, C Manegold, S Paul, P Paoletti, L Einhorn, P Bunn

Trial Locations

All sites in which the trial HCRN-LUN01-15 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278